Comments Regarding Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products Share page: Docket Number: FDA-2024-D-4689 Download Document Issues: Other Issues Related Posts Q&A for CHPA Members: The Impact of Tariffs on Consumer Healthcare Companies Additional Tariff Documents and Informational Opportunities Tariffs: Ongoing Actions and Industry Guidance